Stock listing
Dusseldorf:YB4P Savara, Inc. Aktie
German listing (Dusseldorf) of Savara, Inc. · home listing NASDAQ:SVRA
Follow Savara, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SVRA
$4.82 USD -0.13 (-2.6%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SVRA
- Day range
- $4.75 – $4.97 USDOct 30, 2026
- Volume
- 1.41M sharesOct 30, 2026
- Market cap
- $990.3M USDAt the close on Oct 30, 2026 · price × 205.5M shares outstanding
- 52-week range
- $3.86 – $7.01 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $10.02M USDMedian day 1.61M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SVRA · Home | $4.82 USD | -0.13 (-2.6%) | 1,409,437 | $4.936 | $4.97 | $4.75 | $4.95 | Close on Oct 30, 2026 |
| Frankfurt:YB4P | €4.258 EUR | +0.287 (+7.2%) | — | €4.373 | €4.373 | €4.258 | €3.971 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SVRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.82 | -0.13 | -2.6% | $4.936 | $4.97 | $4.75 | 1,409,437 | |
| $4.95 | -0.07 | -1.4% | $5.05 | $5.13 | $4.915 | 1,740,801 | |
| $5.02 | +0.16 | +3.3% | $4.82 | $5.05 | $4.775 | 1,785,855 | |
| $4.86 | +0.34 | +7.5% | $4.49 | $4.905 | $4.45 | 3,590,010 | |
| $4.52 | +0.30 | +7.1% | $4.30 | $4.535 | $4.216 | 3,441,276 | |
| $4.22 | -0.32 | -7.0% | $4.52 | $4.58 | $4.13 | 2,827,900 | |
| $4.54 | -0.13 | -2.8% | $4.65 | $4.75 | $4.45 | 2,709,700 | |
| $4.67 | -0.09 | -1.9% | $4.79 | $4.945 | $4.66 | 2,086,100 | |
| $4.76 | +0.13 | +2.8% | $4.64 | $4.99 | $4.60 | 4,417,400 | |
| $4.63 | +0.18 | +4.0% | $4.53 | $4.705 | $4.495 | 1,560,300 | |
| $4.45 | -0.29 | -6.1% | $4.75 | $4.77 | $4.44 | 2,235,000 | |
| $4.74 | -0.02 | -0.4% | $4.76 | $4.90 | $4.72 | 1,690,900 | |
| $4.76 | -0.02 | -0.4% | $4.71 | $4.82 | $4.65 | 2,574,300 | |
| $4.78 | -0.06 | -1.2% | $4.84 | $5.02 | $4.76 | 3,742,100 | |
| $4.84 | -0.08 | -1.6% | $4.93 | $5.00 | $4.81 | 1,306,700 | |
| $4.92 | +0.09 | +1.9% | $4.82 | $4.975 | $4.81 | 1,529,100 | |
| $4.83 | -0.05 | -1.0% | $4.85 | $4.92 | $4.635 | 2,514,600 | |
| $4.88 | +0.23 | +4.9% | $4.74 | $5.05 | $4.69 | 2,414,900 | |
| $4.65 | -0.13 | -2.7% | $4.82 | $4.84 | $4.60 | 2,289,400 | |
| $4.78 | -0.03 | -0.6% | $4.85 | $4.915 | $4.71 | 2,862,300 | |
| $4.81 | -0.235 | -4.7% | $5.10 | $5.16 | $4.765 | 2,653,300 | |
| $5.045 | -0.115 | -2.2% | $5.15 | $5.24 | $5.03 | 2,549,600 | |
| $5.16 | +0.08 | +1.6% | $5.15 | $5.24 | $5.05 | 6,051,300 | |
| $5.08 | +0.01 | +0.2% | $5.07 | $5.19 | $5.00 | 2,034,700 | |
| $5.07 | +0.07 | +1.4% | $4.97 | $5.155 | $4.86 | 4,371,000 | |
| $5.00 | -0.07 | -1.4% | $5.08 | $5.18 | $4.87 | 2,451,000 | |
| $5.07 | +0.07 | +1.4% | $5.03 | $5.085 | $4.884 | 2,499,200 | |
| $5.00 | -0.30 | -5.7% | $5.30 | $5.34 | $4.90 | 3,352,900 | |
| $5.30 | -0.15 | -2.8% | $5.52 | $5.525 | $5.29 | 1,412,900 | |
| $5.45 | +0.08 | +1.5% | $5.44 | $5.51 | $5.36 | 1,311,900 | |
| $5.37 | -0.05 | -0.9% | $5.42 | $5.47 | $5.305 | 2,181,900 | |
| $5.42 | +0.29 | +5.7% | $5.23 | $5.465 | $5.22 | 1,228,700 | |
| $5.13 | -0.13 | -2.5% | $5.29 | $5.351 | $5.105 | 1,127,000 | |
| $5.26 | -0.08 | -1.5% | $5.33 | $5.34 | $5.175 | 1,301,400 | |
| $5.34 | +0.04 | +0.8% | $5.33 | $5.43 | $5.28 | 1,310,100 | |
| $5.30 | -0.02 | -0.4% | $5.38 | $5.395 | $5.27 | 1,063,700 | |
| $5.32 | -0.095 | -1.8% | $5.34 | $5.46 | $5.24 | 1,525,400 | |
| $5.415 | -0.115 | -2.1% | $5.48 | $5.57 | $5.37 | 1,095,500 | |
| $5.53 | +0.16 | +3.0% | $5.27 | $5.63 | $5.26 | 1,660,800 | |
| $5.37 | 0.00 | 0.0% | $5.32 | $5.39 | $5.31 | 625,200 | |
| $5.37 | -0.09 | -1.6% | $5.52 | $5.52 | $5.29 | 1,240,400 | |
| $5.46 | +0.11 | +2.1% | $5.47 | $5.56 | $5.365 | 1,216,800 | |
| $5.35 | -0.04 | -0.7% | $5.32 | $5.405 | $5.29 | 1,042,100 | |
| $5.39 | +0.13 | +2.5% | $5.25 | $5.44 | $5.21 | 1,958,700 | |
| $5.26 | -0.23 | -4.2% | $5.48 | $5.51 | $5.25 | 1,336,300 | |
| $5.49 | -0.12 | -2.1% | $5.59 | $5.66 | $5.485 | 1,595,300 | |
| $5.61 | +0.01 | +0.2% | $5.58 | $5.68 | $5.51 | 1,529,800 | |
| $5.60 | +0.04 | +0.7% | $5.69 | $5.72 | $5.52 | 1,608,654 | |
| $5.56 | -0.03 | -0.5% | $5.60 | $5.60 | $5.425 | 1,323,851 | |
| $5.59 | +0.10 | +1.8% | $5.54 | $5.64 | $5.50 | 3,035,200 | |
| $5.49 | -0.09 | -1.6% | $5.52 | $5.59 | $5.26 | 2,541,800 | |
| $5.58 | +0.21 | +3.9% | $5.49 | $5.60 | $5.395 | 1,298,200 | |
| $5.37 | 0.00 | 0.0% | $5.33 | $5.43 | $5.285 | 1,510,400 | |
| $5.37 | -0.01 | -0.2% | $5.39 | $5.43 | $5.285 | 1,206,700 | |
| $5.38 | +0.11 | +2.1% | $5.25 | $5.40 | $5.14 | 1,650,100 | |
| $5.27 | -0.43 | -7.5% | $5.75 | $5.79 | $5.25 | 1,874,400 | |
| $5.70 | +0.13 | +2.3% | $5.91 | $5.92 | $5.575 | 1,175,000 | |
| $5.57 | -0.16 | -2.8% | $5.81 | $5.98 | $5.53 | 1,263,700 | |
| $5.73 | -0.10 | -1.7% | $5.82 | $5.93 | $5.63 | 1,206,600 | |
| $5.83 | +0.04 | +0.7% | $5.87 | $5.99 | $5.785 | 1,586,200 | |
| $5.79 | +0.28 | +5.1% | $5.52 | $5.81 | $5.52 | 1,007,700 | |
| $5.51 | +0.10 | +1.8% | $5.43 | $5.53 | $5.36 | 1,602,600 | |
| $5.41 | +0.08 | +1.5% | $5.45 | $5.525 | $5.375 | 1,361,600 | |
| $5.33 | -0.13 | -2.4% | $5.44 | $5.49 | $5.31 | 1,639,600 | |
| $5.46 | -0.08 | -1.4% | $5.54 | $5.63 | $5.35 | 1,168,500 | |
| $5.54 | +0.26 | +4.9% | $5.31 | $5.55 | $5.255 | 1,240,700 |
- Ticker
- Dusseldorf:YB4P
- Asset type
- Stock
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 21, 2026
Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment
Latest deck · Sep 6, 2026
Technical Presentation (September 2026)
Technical · 11 slides
Latest news
Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment
Oct 21, 2026
Closed $4.67 (-1.9%) on Oct 21, 2026
Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026
Oct 12, 2026
Closed $4.78 (-1.2%) on Oct 13, 2026
Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP)
Aug 25, 2026
Closed $5.60 (+0.7%) on Aug 25, 2026
Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026
Aug 24, 2026
Closed $5.60 (+0.7%) on Aug 25, 2026
Savara Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026
Closed $5.70 (+2.3%) on Aug 12, 2026
Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041
Jul 30, 2026
Closed $5.54 (+4.9%) on Jul 30, 2026
Savara Announces Chief Financial and Administrative Officer Transition
Jun 8, 2026
Closed $4.93 (-2.6%) on Jun 9, 2026
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Closed $5.09 (-2.3%) on May 28, 2026
Decks
Technical Presentation (September 2026)
Technical · 11 slides · Sep 6, 2026
American Thoracic Society (ATS) 2026 International Conference
Conference · 9 slides · May 18, 2026
Investor Presentation (January 2026)
Investor deck · 47 slides · Jan 9, 2026
Investor Presentation (October 2025)
Investor deck · 15 slides · Oct 29, 2025
Savara, Inc. on 6ix
- News releases
- 31 in the last 12 months · 156 in all · newest Oct 21, 2026 · oldest 2019
- Decks
- 65 decks · latest Sep 6, 2026
Where Savara, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SVRA · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A2DQ2B | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2DQ2B | LS Exchange | Germany | EUR |
| gettex:YB4P | gettex | Germany | EUR |
| Frankfurt:YB4P | Frankfurt | Germany | EUR |
| BOATS:SVRA | BOATS | United States | USD |
| Tradegate:YB4P | Tradegate | Germany | EUR |
| Dusseldorf:YB4P · This page | Dusseldorf | Germany | EUR |
| Munich:YB4P | Munich | Germany | EUR |
| Stuttgart:YB4P | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Savara, Inc.